BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23467026)

  • 21. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
    Shi F; Yang X; Gong Y; Shi R; Yang X; Naren D; Wu J
    Anticancer Drugs; 2015 Apr; 26(4):410-21. PubMed ID: 25535978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
    Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Baghdadi TA; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS
    Clin Cancer Res; 2012 Jan; 18(2):360-369. PubMed ID: 22096027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
    Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
    Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.
    Osborne MJ; Borden KL
    Immunol Rev; 2015 Jan; 263(1):210-23. PubMed ID: 25510279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TAK1-NF-κB axis as therapeutic target for AML.
    Bosman MC; Schepers H; Jaques J; Brouwers-Vos AZ; Quax WJ; Schuringa JJ; Vellenga E
    Blood; 2014 Nov; 124(20):3130-40. PubMed ID: 25287709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells.
    Zhang H; Xu H; Zhang R; Zhao X; Liang M; Wei F
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):257-266. PubMed ID: 32696214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The eukaryotic translation initiation factor eIF4E unexpectedly acts in splicing thereby coupling mRNA processing with translation: eIF4E induces widescale splicing reprogramming providing system-wide connectivity between splicing, nuclear mRNA export and translation.
    Borden KLB
    Bioessays; 2024 Jan; 46(1):e2300145. PubMed ID: 37926700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
    Zhou J; Ching YQ; Chng WJ
    Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
    Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
    Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
    Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
    Kagoya Y; Yoshimi A; Kataoka K; Nakagawa M; Kumano K; Arai S; Kobayashi H; Saito T; Iwakura Y; Kurokawa M
    J Clin Invest; 2014 Feb; 124(2):528-42. PubMed ID: 24382349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brd4 modulates the innate immune response through Mnk2-eIF4E pathway-dependent translational control of IκBα.
    Bao Y; Wu X; Chen J; Hu X; Zeng F; Cheng J; Jin H; Lin X; Chen LF
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3993-E4001. PubMed ID: 28461486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and characterization of conserved binding of eIF4E 1 (CBE1), a eukaryotic translation initiation factor 4E-binding plant protein.
    Patrick RM; Lee JCH; Teetsel JRJ; Yang SH; Choy GS; Browning KS
    J Biol Chem; 2018 Nov; 293(44):17240-17247. PubMed ID: 30213859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional repression of Cdc25B by IER5 inhibits the proliferation of leukemic progenitor cells through NF-YB and p300 in acute myeloid leukemia.
    Nakamura S; Nagata Y; Tan L; Takemura T; Shibata K; Fujie M; Fujisawa S; Tanaka Y; Toda M; Makita R; Tsunekawa K; Yamada M; Yamaoka M; Yamashita J; Ohnishi K; Yamashita M
    PLoS One; 2011; 6(11):e28011. PubMed ID: 22132193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
    Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
    Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.
    Ge Y; Cheng R; Zhou Y; Shen J; Peng L; Xu X; Dai Q; Liu P; Wang H; Ma X; Jia J; Chen Z
    Mol Cell Biochem; 2012 Sep; 368(1-2):17-25. PubMed ID: 22614784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.